InvestorsHub Logo
Followers 209
Posts 32159
Boards Moderated 1
Alias Born 06/30/2009

Re: seek the light post# 278764

Thursday, 12/26/2019 9:59:38 AM

Thursday, December 26, 2019 9:59:38 AM

Post# of 403033
Is that what he did at Revance? Maybe YOU should read his history.

Anyway, what's your point when you say "he has a history of leaving BEFORE companies do phase 3 Trials even on very successful drugs"?
Are you suggesting that he has a history of poor judgment and his departure portends good things for B-OM? Are you really saying that?

Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer (Brilacidin)
Results Point of Contact
Name/Title: Arthur P. Bertolino MD, PhD, MBA
Organization: Innovation Pharmaceuticals Inc.
Phone: 978.921.4125
EMail: abertolino@IPharmInc.com

Not any more.

https://clinicaltrials.gov/ct2/show/results/NCT02324335?term=%22innovation+pharmaceuticals%22&draw=2&rank=3

But can it core A apple?
Yes Ralph, of course it can core A apple.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News